DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Saini SD, Fendrick AM, Scheiman JM.
Cost-effectiveness analysis: cardiovascular benefits of proton pump inhibitor co-therapy in patients using aspirin for secondary prevention.
Aliment Pharmacol Ther 2011;
34: 243-251.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.